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Summary We report a case of possible infective endocarditis without fever presenting with an
acutely ischemic limb with prior antimicrobial therapy preventing identification by culture of a
microorganism. 16S ribosomal DNA sequencing led to the identification of Staphylococcus
lugdunensis from an embolus removed at surgery and subsequent successful antibiotic treatment.
We review the utility of 16S ribosomal DNA sequencing in diagnosing infective endocarditis and
other infectious conditions.
# 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.Introduction
The diagnosis of culture-negative infective endocarditis
continues to be challenging. The Duke’s criteria have defi-
ciencies in the setting of culture-negative infective endo-
carditis.1 New molecular methods may assist in the diagnosis
of this difficult group of patients. Staphylococcus lugdunensis
has been increasingly recognized as a cause of infective
endocarditis with high mortality.2 We report a successfully
treated case of culture-negative infective endocarditis
where the organism was identified using 16S ribosomal
DNA sequencing.* Corresponding author. Tel.: +65 63577925; fax: +65 62524056.
E-mail address: surinder_pada_kaur@ttsh.com.sg (S. Pada).
1201-9712/$36.00 # 2009 International Society for Infectious Diseases.
doi:10.1016/j.ijid.2009.02.019Case report
A 30-year-old male was hospitalized with sudden left leg
pain, weakness and numbness. There was no fever, chest or
abdominal pain, shortness of breath or pain in other limbs. He
had no trauma to the limb or dental problems. He was
systemically well before admission and had no history of
rheumatic heart disease or injecting drug use. He suffered
from varicose veins and childhood asthma. He worked as a
cook, was a smoker, and had body piercing.
On admission, physical examination revealed a cold, pul-
seless, pale left leg. Capillary return exceeded two seconds.
He was afebrile with dual heart sounds and no murmur. There
were no peripheral stigmata of endocarditis and no hepatos-
plenomegaly. He had a leukocytosis of 17.4  109/l with a
neutrophilia of 16.2  109/l. Chest X-ray was normal. BloodPublished by Elsevier Ltd. All rights reserved.
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acute limb ischemia without suspected sepsis.
An emergency embolectomy was performed to relieve the
lower limb ischemia. A clot was removed from the superficial
femoral artery, common femoral artery and femoris pro-
funda. His post-operative recovery was uneventful. A speci-
men of the clot was sent for histology but none for
microbiology. Peri-operatively, he was commenced on intra-
venous amoxicillin—clavulanate, which was converted to oral
therapy after two days.
The histology of the clot subsequently showed a fibrin
thrombus with multiple colonies of Gram-positive cocci.
Infective endocarditis with embolic complications was sus-
pected. A trans-thoracic echocardiogram showed a dilated
left atrium and ventricle, mitral valve thickening with ante-
rior leaflet prolapse, and aortic regurgitation. A trans-eso-
phageal echocardiogram revealed mitral valve prolapse and
mitral regurgitation with no vegetations, intracardiac shunts
or thrombus. A computed tomography aortogram revealed
renal parenchymal infarcts.
Three sets of blood cultures collected after stopping oral
amoxicillin—clavulanate for 48 hours were sterile. DNA was
extracted from the clot with the QIAamp DNA mini kit tissue
protocol after sections of the clot in paraffin blocks had
been treated with xylene followed by ethanol. 16S rDNA
PCR was performed with 5 ml DNA template (F —
50agagtttgatca-tggctcag30; R — 50ggactaccagggtatctaat30).
The PCR product was cleaned with the QIAquick PCR pur-
ification kit and sequenced with the same primers with a Big
Dye Terminator kit on an ABI 3100 genetic analyzer. The
sequence yielded a perfect match over 745 base pairs with
S. lugdunensis sequences found in the GenBank database
with the use of the NCBI web-based BLAST program. As 68%
of S. lugdunensis at our institution were susceptible to
penicillin compared with 96% to cloxacillin, we treated
him with 6 weeks of intravenous cefazolin as an outpatient.
He made a full recovery and has remained well at follow-up
at six months.
Discussion
Our patient had possible infective endocarditis by Duke’s
criteria, with two minor criteria of predisposing heart con-
dition and arterial emboli and one major echocardiographic
criterion of new valvular regurgitation.1 However there was
no microbiologic diagnosis. Empiric treatment with ceftriax-
one or penicillin and gentamicin may not have been effective
for S. lugdunensis, which in our institution was resistant to
penicillin in 32%, similar to 24% with beta-lactamase produc-
tion reported elsewhere.3
Coagulase-negative staphylococcal endocarditis is not
common, accounting for 6.6% of non-injecting drug use
native valve infective endocarditis, with 85% of cases caused
by Staphylococcus epidermidis.4 Compared with Staphylo-
coccus aureus, coagulase-negative staphylococcal endocar-
ditis has been associated with less systemic emboli but more
cardiac abscess and greater need for surgery. Compared with
streptococcal endocarditis, it has been associated with
greater risk of heart failure, cardiac abscess, systemic
emboli, need for surgery and mortality.4
S. lugdunensis is particularly aggressive as a pathogen for
infective endocarditis. Anguera et al. reported 10 cases andreviewed 59 from published studies.5 The mean age of
patients was 55 years and 49% were male. Native valve
endocarditis comprised 77%, with mitral valve involvement
in 55% and aortic valve in 28%. Notably, heart failure occurred
in 45%, cardiac abscess in 19%, systemic emboli in 30%, need
for surgery in 51% and death in 42%. Antibiotic treatment and
surgery were significantly associated with less mortality (29%
vs. 57%, p = 0.04). Seenivasan and Yu reported one case and
reviewed 47 previously reported cases, and noted similar
findings.2 Median age was 64 years and 66%weremale. Native
valve endocarditis comprised 81%, with mitral valve involve-
ment in 49% and aortic valve in 26%. Cardiac complications
occurred in 53% and systemic emboli in 32%. Of note, the
portal of entry was cutaneous in 21 of 22 cases, and in 10 of 21
it was localized to the perineal region.
Our patient was able to receive effective antibiotic treat-
ment as a result of molecular diagnosis with 16S ribosomal
DNA sequencing. Without the results of 16S ribosomal DNA
sequencing, he would have been treated as a case of culture-
negative endocarditis, where prior antibiotic therapy was the
commonest cause (45—69%).6—8 In the largest series to date
of culture-negative endocarditis based on findings from a
diagnostic referral center,9 48% of 348 cases were due to
Coxiella burnetii and 28% to Bartonella.
16S ribosomal DNA comprises variable and highly con-
served regions, the latter suited to identify all possible
bacteria to genus or species level.10 Its utility in infective
endocarditis has been reported in three studies. In one study
where it was applied to 18 valves and compared with valve
and blood cultures, PCR results agreed with valve culture in
two and with blood culture in nine (where valve culture was
negative). It identified two cases where both valve and blood
cultures were negative. Blood culture was positive in two
cases where both valve and PCR were negative.11 A second
study of 46 cases with valve tissues showed that it was able to
identify 26 of 30 blood culture-positive cases and five of six
blood culture-negative cases, all of which were definite
infective endocarditis by Dukes’ criteria.12 The last study
of 49 cases with resected valves, when compared with results
of blood and valve cultures as well as Dukes’ criteria,
reported that the sensitivity, specificity, and positive and
negative predictive values for PCR in native valve endocar-
ditis were 94%, 100%, 100% and 90%, respectively, compared
with 18%, 89%, 75% and 36%, respectively, for valve culture.13
Consequently Lisby et al. proposed that the major micro-
biologic criterion be modified to include identification of
microorganisms consistent with endocarditis by molecular
microbiology and the major pathologic criterion be modified
to include identification of microorganism consistent with
endocarditis in vegetation. In addition, they proposed that
the minor microbiologic criterion be modified to include
identification of microorganism consistent with endocarditis
from specimens other than blood, vegetation or embolus,
e.g., brain and splenic abscess, mycotic aneurysm.10
16S ribosomal DNA sequencing is useful in other clinical
settings as well. In bacterial keratitis, in a study of 28
patients, 11 of whom had microbiologically documented
bacterial keratitis, PCR was positive in 82% with 100% con-
cordance with culture. Of 17 culture-negative patients, PCR
was negative in 100%, suggesting its utility in excluding
bacterial keratitis.14 In bacterial meningitis, there was good
concordance between culture-positive and PCR-positive
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found a sensitivity of 86%, specificity of 97%, positive pre-
dictive value of 80% and negative predictive value of 98%
compared with culture.15 This method has also been useful in
the diagnosis of central vascular catheter-associated bacter-
ial infections.16
Hence, the advantages of 16S ribosomal DNA sequencing lie
in the detection of non-cultivatable microorganisms or speci-
mens rendered sterile by prior antimicrobial therapy. Poten-
tially it can rapidly detect rare and fastidiousmicroorganisms.
Its disadvantages are the lack of antimicrobial susceptibility,
special expertise is required, cost, and contamination invali-
dating the results. Thus, it is a useful adjunct to microbiologic
cultures in the diagnosis of infective endocarditis.
In conclusion, the existing Duke’s criteria suffer from lack
of sensitivity for culture-negative endocarditis. 16S riboso-
mal DNA sequencing is a useful diagnostic adjunct where
culture fails to yield a causative organism and where clinical
suspicion of infective endocarditis remains high.
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